Ausgabe 7/2012
Special Issue: Biomarkers of neurodegeneration: beyond Alzheimer’s disease and cerebrospinal fluid
Inhalt (16 Artikel)
α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system
Brit Mollenhauer, Ellen Trautmann, Birgit Otte, Juliana Ng, Annette Spreer, Peter Lange, Friederike Sixel-Döring, Mansoureh Hakimi, Jean-Paul VonSattel, Robert Nussbaum, Claudia Trenkwalder, Michael G. Schlossmacher
CSF markers in amyotrophic lateral sclerosis
Joanna Tarasiuk, Alina Kułakowska, Wiesław Drozdowski, Johannes Kornhuber, Piotr Lewczuk
Increased concentration of the CSF Tau protein and its phosphorylated form in the late juvenile metachromatic leukodystrophy form: a case report
Joanna Tarasiuk, Katarzyna Kapica-Topczewska, Alina Kułakowska, Dorota Halicka, Wiesław Drozdowski, Johannes Kornhuber, Piotr Lewczuk
Plasmin system of Alzheimer’s disease patients: CSF analysis
Alessandro Martorana, Giulia M. Sancesario, Zaira Esposito, Marzia Nuccetelli, Roberto Sorge, Amanda Formosa, Vincenzo Dinallo, Giorgio Bernardi, Sergio Bernardini, Giuseppe Sancesario
Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer’s disease patients
Alessandro Martorana, Zaira Esposito, Francesco Di Lorenzo, Viola Giacobbe, Giulia Maria Sancesario, Giulia Bucchi, Sonia Bonnì, Sergio Bernardini, Roberto Sorge, Giuseppe Sancesario, Giorgio Bernardi, Carlo Caltagirone, Giacomo Koch
Multidimensional plasma protein separation technique for identification of potential Alzheimer’s disease plasma biomarkers: a pilot study
Andreas Wolfram Henkel, Katharina Müller, Piotr Lewczuk, Thorsten Müller, Katrin Marcus, Johannes Kornhuber, Jens Wiltfang
Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease
Jonny Daborg, Ulf Andreasson, Marcela Pekna, Ronald Lautner, Eric Hanse, Lennart Minthon, Kaj Blennow, Oskar Hansson, Henrik Zetterberg
Cerebrospinal fluid β-amyloid1–42 correlates with rate of progression in Alzheimer’s disease
George S. Vlachos, George P. Paraskevas, Dimitris Naoumis, Elizabeth Kapaki
Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
Mirko Bibl, Marion Gallus, Volker Welge, Hermann Esselmann, Stefanie Wolf, Eckart Rüther, Jens Wiltfang
Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer’s disease
Isis A. Zainaghi, Leda L. Talib, Breno S. Diniz, Wagner F. Gattaz, Orestes V. Forlenza
Monte Carlo feature selection and rule-based models to predict Alzheimer’s disease in mild cognitive impairment
Marcin Kruczyk, Henrik Zetterberg, Oskar Hansson, Sindre Rolstad, Lennart Minthon, Anders Wallin, Kaj Blennow, Jan Komorowski, Mats Gunnar Andersson
A novel ARC gene polymorphism is associated with reduced risk of Alzheimer’s disease
Sara Landgren, Malin von Otter, Mona Seibt Palmér, Caroline Zetterström, Staffan Nilsson, Ingmar Skoog, Deborah R. Gustafson, Lennart Minthon, Anders Wallin, Niels Andreasen, Nenad Bogdanovic, Jan Marcusson, Kaj Blennow, Henrik Zetterberg, Petronella Kettunen
Longitudinal plasma amyloid beta as a biomarker of Alzheimer’s disease
Robert A. Rissman, John Q. Trojanowski, Leslie M. Shaw, Paul S. Aisen
Clinical phenotypes and genetic biomarkers of FTLD
Daniela Galimberti, Elio Scarpini
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD
Alessandro Stefani, Livia Brusa, Enrica Olivola, Mariangela Pierantozzi, Alessandro Martorana